![logo onxeo large](/sites/techtransfer/files/styles/rectangle_petit_crop/public/medias/images/2017-08/l_onxeologo.jpg?h=a955cd85&itok=mk6miz9G)
DNA Thearpeutics was acquired in 2016 by ONXEO. First-in-class, signal-interfering DNA molecule based on one of the most promising new approaches in cancer treatment
www.onxeo.com
Innovation
The DBAIT success story
03/02/2016